Range Low Price High Price Comment
30 days $35.86 $50.65 Wednesday, 1st May 2024 VERA stock ended at $42.32. This is 7.11% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 10.90% from a day low at $39.54 to a day high of $43.85.
90 days $35.86 $50.69
52 weeks $6.74 $50.69

Historical Vera Therapeutics, Inc. prices

Date Open High Low Close Volume
May 01, 2024 $39.54 $43.85 $39.54 $42.32 1 337 063
Apr 30, 2024 $40.90 $41.75 $38.85 $39.51 748 016
Apr 29, 2024 $40.21 $42.08 $40.21 $41.38 651 409
Apr 26, 2024 $38.75 $40.25 $38.40 $39.65 822 396
Apr 25, 2024 $38.25 $39.89 $37.84 $38.69 845 497
Apr 24, 2024 $39.65 $40.73 $38.20 $39.95 764 060
Apr 23, 2024 $39.37 $43.05 $39.15 $39.52 1 216 326
Apr 22, 2024 $38.40 $39.79 $37.80 $39.13 708 128
Apr 19, 2024 $39.51 $40.34 $36.34 $38.00 1 360 513
Apr 18, 2024 $39.63 $40.71 $38.86 $39.48 842 186
Apr 17, 2024 $42.65 $42.65 $40.01 $40.01 1 048 051
Apr 16, 2024 $45.92 $47.15 $42.22 $42.57 1 119 478
Apr 15, 2024 $47.46 $47.64 $45.75 $46.53 1 111 516
Apr 12, 2024 $48.70 $50.65 $46.25 $47.97 2 150 203
Apr 11, 2024 $42.01 $49.29 $41.63 $48.82 4 603 669
Apr 10, 2024 $36.69 $42.55 $35.86 $41.62 1 656 883
Apr 09, 2024 $38.82 $39.11 $37.13 $37.91 561 878
Apr 08, 2024 $36.63 $39.53 $36.60 $38.63 518 701
Apr 05, 2024 $37.14 $38.51 $36.73 $37.52 927 088
Apr 04, 2024 $40.00 $40.75 $37.33 $37.41 1 283 118
Apr 03, 2024 $40.30 $40.39 $37.53 $39.60 847 963
Apr 02, 2024 $40.80 $41.39 $39.63 $40.85 619 477
Apr 01, 2024 $42.98 $43.31 $41.76 $42.35 439 425
Mar 28, 2024 $43.84 $44.44 $42.38 $43.12 652 619
Mar 27, 2024 $42.33 $44.02 $41.50 $43.83 483 573
Click to get the best stock tips daily for free!

About Vera Therapeutics, Inc.

Vera Therapeutics. Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of ... VERA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT